welbournes

Department of Health and Social Care (DHSC) has issued an update to the medicine supply notification for Voriconazole (VFEND®) 40mg/ml powder for oral suspension issued on 25 March 2021. MSN/2021/016U Tier 2 – medium impact Date of issue 17th August 2022 Voriconazole 40mg/ml powder for oral suspension is out of stock until late August 2022. [...]

The post Medicine Supply Notification: Voriconazole (VFEND® ) 40mg/ml powder for oral suspension appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Acebutolol (Sectral®) 100mg and 200mg capsules and 400mg tablets. Update to MSN/2021/051 Tier 2 – medium impact Date of issue 17th August 2022 Following discontinuation of acebutolol (Sectral®) 100mg capsules, Neon Healthcare have now discontinued 200mg capsules and 400mg tablets, with [...]

The post Medicine Supply Notification: Acebutolol (Sectral® )100mg and 200mg capsules and 400mg tablets appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bowel evacuation preparations. MSN/2022/071 Tier 3 – high impact Date of issue 17th August 2022 Moviprep® oral powder sachets are out of stock until w/c 22nd August 2022. Moviprep® orange oral powder sachets are out of stock until w/c 3rd October [...]

The post Medicine Supply Notification: Bowel evacuation preparations appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Diltiazem (Tildiem Retard®) 90mg and 120mg modified-release tablets. MSN/2022/070 Tier 2 – medium impact Date of issue 17th August 2022 Diltiazem (Tildiem Retard®) 90mg modified-release tablets are out of stock until w/c 17th October 2022. Diltiazem (Tildiem Retard®) 120mg modified-release tablets [...]

The post Medicine Supply Notification: Diltiazem (Tildiem Retard® ) 90mg and 120mg modified-release tablets appeared first on PSNC Website.

Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets (Accord) Drug alert number: EL (22)A/35 Date issued: 17 August 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rosuvastatin 5 mg film-coated tablets PL 20075/0402 Batch Number Expiry Date [...]

The post MHRA Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets appeared first on PSNC Website.